Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 14 | 2023 | 792 | 1.540 |
Why?
|
| Alzheimer Disease | 11 | 2023 | 7165 | 0.530 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 5 | 2014 | 461 | 0.390 |
Why?
|
| tau Proteins | 5 | 2022 | 1623 | 0.310 |
Why?
|
| Amyloid beta-Peptides | 6 | 2023 | 3167 | 0.300 |
Why?
|
| Cerebrovascular Disorders | 2 | 2022 | 1508 | 0.260 |
Why?
|
| Neurofilament Proteins | 3 | 2021 | 350 | 0.260 |
Why?
|
| Blood Transfusion | 2 | 2020 | 1246 | 0.260 |
Why?
|
| Influenza, Human | 5 | 2014 | 1344 | 0.250 |
Why?
|
| Nerve Degeneration | 2 | 2022 | 790 | 0.230 |
Why?
|
| Infarction | 1 | 2020 | 223 | 0.190 |
Why?
|
| Echovirus Infections | 1 | 2018 | 7 | 0.180 |
Why?
|
| Foot-and-Mouth Disease | 1 | 2018 | 7 | 0.180 |
Why?
|
| Hypertrophy | 1 | 2020 | 579 | 0.180 |
Why?
|
| Enterovirus Infections | 1 | 2018 | 65 | 0.170 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 2046 | 0.160 |
Why?
|
| Medication Therapy Management | 1 | 2017 | 128 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 2020 | 416 | 0.150 |
Why?
|
| Amyloid | 1 | 2020 | 710 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 667 | 0.140 |
Why?
|
| Medication Adherence | 2 | 2017 | 2019 | 0.140 |
Why?
|
| Nootropic Agents | 1 | 2016 | 162 | 0.140 |
Why?
|
| Diuretics | 1 | 2017 | 579 | 0.130 |
Why?
|
| Singapore | 5 | 2014 | 305 | 0.130 |
Why?
|
| Disease Outbreaks | 4 | 2011 | 1709 | 0.130 |
Why?
|
| Stilbenes | 1 | 2015 | 199 | 0.120 |
Why?
|
| Vitamin E | 1 | 2016 | 842 | 0.110 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 1465 | 0.110 |
Why?
|
| Fluorine Radioisotopes | 1 | 2015 | 460 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2021 | 5141 | 0.100 |
Why?
|
| Myocardial Contraction | 1 | 2016 | 1659 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2015 | 953 | 0.100 |
Why?
|
| Positron-Emission Tomography | 4 | 2023 | 6170 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 1231 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 935 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1489 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2020 | 3235 | 0.090 |
Why?
|
| Neurofibrillary Tangles | 1 | 2011 | 421 | 0.090 |
Why?
|
| Czech Republic | 2 | 2017 | 53 | 0.080 |
Why?
|
| Hypertension | 2 | 2017 | 8161 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5235 | 0.080 |
Why?
|
| Middle Aged | 21 | 2023 | 213752 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2023 | 5703 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 16008 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1268 | 0.070 |
Why?
|
| Seasons | 1 | 2011 | 1433 | 0.070 |
Why?
|
| Adult | 18 | 2023 | 211041 | 0.070 |
Why?
|
| Brain | 3 | 2022 | 24969 | 0.060 |
Why?
|
| Aging | 2 | 2022 | 8358 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2017 | 607 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 23020 | 0.060 |
Why?
|
| Myocardium | 1 | 2016 | 4969 | 0.060 |
Why?
|
| Neurons | 1 | 2022 | 9385 | 0.060 |
Why?
|
| Viral Load | 1 | 2011 | 3231 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2017 | 8528 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2461 | 0.050 |
Why?
|
| Humans | 26 | 2023 | 708843 | 0.050 |
Why?
|
| Gliosis | 1 | 2021 | 240 | 0.050 |
Why?
|
| Male | 18 | 2022 | 349524 | 0.050 |
Why?
|
| Infant | 7 | 2020 | 34261 | 0.050 |
Why?
|
| Female | 19 | 2022 | 375205 | 0.050 |
Why?
|
| Aged | 11 | 2023 | 161488 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2020 | 41081 | 0.050 |
Why?
|
| Enterovirus B, Human | 1 | 2018 | 57 | 0.040 |
Why?
|
| Enterovirus | 1 | 2018 | 65 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2020 | 24433 | 0.040 |
Why?
|
| Encephalitis | 1 | 2021 | 446 | 0.040 |
Why?
|
| Dementia | 2 | 2016 | 2227 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2016 | 119 | 0.040 |
Why?
|
| Age of Onset | 1 | 2003 | 3330 | 0.040 |
Why?
|
| Menopause | 1 | 2003 | 1518 | 0.040 |
Why?
|
| Young Adult | 7 | 2020 | 55940 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 6879 | 0.030 |
Why?
|
| Pandemics | 2 | 2014 | 7089 | 0.030 |
Why?
|
| Heterozygote | 1 | 2021 | 2780 | 0.030 |
Why?
|
| Child | 7 | 2020 | 73636 | 0.030 |
Why?
|
| Age Factors | 3 | 2017 | 18712 | 0.030 |
Why?
|
| Adolescent | 7 | 2020 | 84718 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 959 | 0.030 |
Why?
|
| Necrosis | 1 | 2016 | 1646 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 839 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1688 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1767 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1588 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1714 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15252 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4883 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2011 | 270 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2016 | 2680 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3244 | 0.020 |
Why?
|
| ROC Curve | 1 | 2016 | 3518 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 1880 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 3944 | 0.020 |
Why?
|
| Hospitalization | 3 | 2014 | 9644 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2020 | 71483 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6293 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 614 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12863 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 58184 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2017 | 2758 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1271 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 2950 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13536 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 4006 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 50597 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 13298 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2017 | 39292 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 9754 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 2003 | 313 | 0.010 |
Why?
|
| Risk Factors | 3 | 2016 | 69553 | 0.010 |
Why?
|
| Contrast Media | 1 | 2016 | 5267 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10566 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2011 | 2847 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 11877 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2017 | 3733 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10507 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 9706 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13468 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10019 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2003 | 611 | 0.010 |
Why?
|
| Hormones | 1 | 2003 | 855 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 2421 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2003 | 650 | 0.010 |
Why?
|
| Intelligence | 1 | 2003 | 895 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10339 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23284 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 13274 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 25094 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 41038 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 34151 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16306 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 170486 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 7090 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 20320 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2003 | 12366 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2003 | 21194 | 0.000 |
Why?
|
| Depression | 1 | 2003 | 7202 | 0.000 |
Why?
|
| Mice | 1 | 2011 | 80876 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_